JP2025165980A5 - - Google Patents
Info
- Publication number
- JP2025165980A5 JP2025165980A5 JP2025121129A JP2025121129A JP2025165980A5 JP 2025165980 A5 JP2025165980 A5 JP 2025165980A5 JP 2025121129 A JP2025121129 A JP 2025121129A JP 2025121129 A JP2025121129 A JP 2025121129A JP 2025165980 A5 JP2025165980 A5 JP 2025165980A5
- Authority
- JP
- Japan
- Prior art keywords
- cell population
- interleukin
- cells
- epitope
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1911799.3A GB201911799D0 (en) | 2019-08-16 | 2019-08-16 | Novel Antibodies |
| GB1911799.3 | 2019-08-16 | ||
| GB2010760.3 | 2020-07-13 | ||
| GBGB2010760.3A GB202010760D0 (en) | 2020-07-13 | 2020-07-13 | Novel antibodies |
| GB2012172.9 | 2020-08-05 | ||
| GBGB2012172.9A GB202012172D0 (en) | 2020-08-05 | 2020-08-05 | Gamma delta cell populations |
| PCT/GB2020/051956 WO2021032961A1 (en) | 2019-08-16 | 2020-08-14 | Ex vivo gamma delta t cell populations |
| JP2022509630A JP7764364B2 (ja) | 2019-08-16 | 2020-08-14 | エクスビボγδ Ｔ細胞集団 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022509630A Division JP7764364B2 (ja) | 2019-08-16 | 2020-08-14 | エクスビボγδ Ｔ細胞集団 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025165980A JP2025165980A (ja) | 2025-11-05 |
| JP2025165980A5 true JP2025165980A5 (https=) | 2026-01-19 |
Family
ID=72148175
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022509630A Active JP7764364B2 (ja) | 2019-08-16 | 2020-08-14 | エクスビボγδ Ｔ細胞集団 |
| JP2025121129A Pending JP2025165980A (ja) | 2019-08-16 | 2025-07-18 | エクスビボγδ Ｔ細胞集団 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022509630A Active JP7764364B2 (ja) | 2019-08-16 | 2020-08-14 | エクスビボγδ Ｔ細胞集団 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220290101A1 (https=) |
| EP (1) | EP4013787A1 (https=) |
| JP (2) | JP7764364B2 (https=) |
| KR (1) | KR20220045980A (https=) |
| CN (1) | CN114599783A (https=) |
| AU (1) | AU2020334287A1 (https=) |
| BR (1) | BR112022001416A2 (https=) |
| CA (1) | CA3148588A1 (https=) |
| IL (1) | IL290538A (https=) |
| MX (1) | MX2022001977A (https=) |
| PH (1) | PH12022550373A1 (https=) |
| WO (1) | WO2021032961A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107531787B (zh) | 2015-01-27 | 2022-01-18 | 拉法医疗有限公司 | 靶向cd1d的单域抗体 |
| WO2020060406A1 (en) | 2018-09-19 | 2020-03-26 | Lava Therapeutics B.V. | Novel bispecific antibodies for use in the treatment of hematological malignancies |
| EP4114415A1 (en) | 2020-03-06 | 2023-01-11 | Sorrento Therapeutics, Inc. | Innate immunity killer cells targeting psma positive tumor cells |
| CN116323667A (zh) | 2020-07-08 | 2023-06-23 | 拉法医疗股份有限公司 | 结合PSMA和γ-δT细胞受体的抗体 |
| LT4269444T (lt) | 2020-08-14 | 2024-09-25 | GammaDelta Therapeutics Limited | Daugiaspecifiniai anti-tcr kintamos delta 1 antikūnai |
| GB202013962D0 (en) | 2020-09-04 | 2020-10-21 | Gammadelta Therapeutics Ltd | Immunotherapy composition |
| TW202246338A (zh) * | 2021-02-17 | 2022-12-01 | 英商適應生物治療有限公司 | 抗ＴＣＲδ可變1抗體 |
| AU2022222299A1 (en) | 2021-02-17 | 2023-09-07 | F-Star Therapeutics Limited | Multispecific anti-tcr delta variable 1 antibodies |
| JP2024539088A (ja) * | 2021-10-20 | 2024-10-28 | ユニバーシティ オブ ピッツバーグ －オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション | 腫瘍浸潤ガンマ－デルタｔ細胞を拡大するための方法及び材料 |
| CA3238458A1 (en) * | 2021-11-18 | 2023-05-25 | Regents Of The University Of Minnesota | Large-scale expansion of engineered human gamma delta t cells |
| WO2024259371A2 (en) * | 2023-06-14 | 2024-12-19 | Duke University | COMPOSITIONS FOR AND METHODS OF EXPANDING γδ T CELLS |
| CN121752599A (zh) * | 2023-08-31 | 2026-03-27 | 南京传奇生物科技有限公司 | 抗γδTCR抗体及其用途 |
| CN120058919B (zh) * | 2025-04-29 | 2025-07-18 | 浙江大学杭州国际科创中心 | 抗裂谷热病毒Gn蛋白的单抗及在病毒检测中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103635573B (zh) | 2011-05-19 | 2016-05-11 | 分子医学研究所 | 包含γδT细胞的淋巴细胞系、其组合物及生产方法 |
| GB201506423D0 (en) * | 2015-04-15 | 2015-05-27 | Tc Biopharm Ltd | Gamma delta T cells and uses thereof |
| AU2016274633B2 (en) | 2015-06-09 | 2022-04-21 | Gammadelta Therapeutics Ltd | Methods for the production of TCR gamma delta+ T cells |
| EP4148124A1 (en) | 2015-10-30 | 2023-03-15 | Cancer Research Technology Limited | Expansion of non-haematopoietic tissue-resident gamma delta t cells and uses of these cells |
| EP3454870A4 (en) | 2016-05-12 | 2020-03-04 | Adicet Bio Inc. | METHOD FOR SELECTIVE EXPANSION OF GAMMA DELTA T CELL POPULATIONS AND COMPOSITIONS THEREOF |
| US10546518B2 (en) | 2017-05-15 | 2020-01-28 | Google Llc | Near-eye display with extended effective eyebox via eye tracking |
| US10519236B2 (en) * | 2018-01-23 | 2019-12-31 | New York University | Antibodies specific to delta 1 chain of T cell receptor |
| GB201818243D0 (en) | 2018-11-08 | 2018-12-26 | Gammadelta Therapeutics Ltd | Methods for isolating and expanding cells |
-
2020
- 2020-08-14 US US17/635,479 patent/US20220290101A1/en active Pending
- 2020-08-14 KR KR1020227008249A patent/KR20220045980A/ko active Pending
- 2020-08-14 AU AU2020334287A patent/AU2020334287A1/en active Pending
- 2020-08-14 BR BR112022001416A patent/BR112022001416A2/pt unknown
- 2020-08-14 PH PH1/2022/550373A patent/PH12022550373A1/en unknown
- 2020-08-14 CN CN202080073438.6A patent/CN114599783A/zh active Pending
- 2020-08-14 CA CA3148588A patent/CA3148588A1/en active Pending
- 2020-08-14 JP JP2022509630A patent/JP7764364B2/ja active Active
- 2020-08-14 WO PCT/GB2020/051956 patent/WO2021032961A1/en not_active Ceased
- 2020-08-14 MX MX2022001977A patent/MX2022001977A/es unknown
- 2020-08-14 EP EP20758306.3A patent/EP4013787A1/en active Pending
-
2022
- 2022-02-10 IL IL290538A patent/IL290538A/en unknown
-
2025
- 2025-07-18 JP JP2025121129A patent/JP2025165980A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025165980A5 (https=) | ||
| AU2023233209B2 (en) | Methods of preparing anti-human papillomavirus antigen T cells | |
| Cao et al. | Potentiating tissue-resident type 2 innate lymphoid cells by IL-33 to prevent renal ischemia-reperfusion injury | |
| Diorio et al. | Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks | |
| Li et al. | Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy | |
| Chung et al. | Engineering the human thymic microenvironment to support thymopoiesis in vivo | |
| Yoshimura et al. | Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells | |
| Amens et al. | Immune system effects on breast cancer | |
| Zeng et al. | Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives | |
| Ollé Hurtado et al. | Tumor infiltrating lymphocytes expanded from pediatric neuroblastoma display heterogeneity of phenotype and function | |
| Schiltz et al. | Characterization of tumor-infiltrating lymphocytes derived from human tumors for use as adoptive immunotherapy of cancer | |
| RU2014110897A (ru) | Т-клетки центральной памяти против третьей стороны, способы их получения и их применение в трансплантации и лечении заболеваний | |
| EP3770251A1 (en) | Method for producing natural killer cells | |
| TW201512399A (zh) | Ｎｋ細胞的調製方法 | |
| Liu et al. | Soluble molecules are key in maintaining the immunomodulatory activity of murine mesenchymal stromal cells | |
| US9018004B2 (en) | Method of expanding double negative T cells | |
| Liebertz et al. | Establishment and characterization of a novel head and neck squamous cell carcinoma cell line USC-HN1 | |
| Loebinger et al. | Mesenchymal stem cells as vectors for lung disease | |
| JPWO2021032961A5 (https=) | ||
| Cooke | Acute lung injury after allogeneic stem cell transplantation: from the clinic, to the bench and back again | |
| JPWO2018211115A5 (https=) | ||
| ES2241246T3 (es) | Proceso para la produccion de lineas celulares de mamiferos. | |
| Wang et al. | Update on cancer related issues of mesenchymal stem cell-based therapies | |
| Alanazi et al. | Langerhans Cell Histiocytosis: Story of The Orphan Disease Beyond Dermatology. | |
| JPWO2021113558A5 (https=) |